These therapies, Rybelsus and Wegovy, represent a major shift in the way treating diabetes and, increasingly, weight management . They work as GLP-1 mimetics, mimicking the action of a bodily hormone https://bookmark-template.com/story29290275/copyright-semaglutide-understanding-the-glp-1-revolution